Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 for Plexiform Neurofibromas in NF1
NCT01365468Phase 2Terminated
- Sponsor
- Novartis
- Start
- Apr 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in plexiform neurofibroma (PN), sponsored by Novartis. Started Apr 2012; status: terminated.
02
Drugs
everolimus
03
Conditions
plexiform neurofibroma (PN)
Beyond the preview
Go deeper on NCT01365468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01365468.